| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-11 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |